PROGRAM

Center or Haemato-Oncology, Barts Cancer Institute, UK

Pathology Department, St. Jude Children's Research Hospital, Memphis TN, USA

MLL Munich Leukemia Laboratory, Germany

Hematology and Stem Cell Transplant Center, Marche Nord Hospital, Italy
*High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC)

Centre Hospitalier Universitaire de Nice (CHU de Nice), France

San Martino Hospital, Genoa, Italy & University of Genoa
*High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC)

Hematology and Stem Cell Transplant Center, Marche Nord Hospital, Italy
*High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC)

Department of Internal Medicine III, University Hospital of Ulm, Germany

Hematology Division, A. Cardarelli Hospital, Naples, Italy

Hematology and Stem Cell Transplant Center, AORMN Hospital, Italy

Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

MD Anderson Cancer Center, Houston TX, USA

MD Anderson Cancer Center Madrid, Spain

Hematology and Stem Cell Transplant Center, Marche Nord Hospital, Italy

Beatson Cancer Centre, Glasgow, UK

Hematology and Stem Cell Transplant Center, Marche Nord Hospital, Italy

Hematology and Stem Cell Transplant Center, Marche Nord Hospital, Italy

Beatson Cancer Centre, Glasgow, UK

Department of Leukemia at MD Anderson Cancer Center, USA

St. Orsola - Malpighi Polyclinic, Bologna University, Italy

Gene Center, Munich and Ludwig Maximilian University of Munich, Germany

Hematology and Stem Cell Transplant Center, Marche Nord Hospital, Italy

Center or Haemato-Oncology, Barts Cancer Institute, UK

Pathology Department, St. Jude Children's Research Hospital, Memphis TN, USA

MLL Munich Leukemia Laboratory, Germany

MD Anderson Cancer Center, Houston TX, USA

MD Anderson Cancer Center Madrid, Spain

Department of Leukemia at MD Anderson Cancer Center, USA

Gene Center, Munich and Ludwig Maximilian University of Munich, Germany

Department of Translational Medicine, University of Easter Piedmont, Italy

Experimental, Diagnostic and Specialty Medicine - DIMES, Bologna University, Italy

Hematology & Internal Medicine, University of Turin, Italy

Medical Faculty of Mannheim at Heidelberg University, Germany

IRCCS/SIRHHC Scientific Institute for Research, Hospitalization and Health Care "Dino Amadori" Meldola (FC), Italy

St. James’s University Hospital, Leeds, UK

Hematology Section, Azienda Ospedaliero-Universitaria S. Anna, University of Ferrara, Italy

Department of Onco-Hematology, San Raffaele Scientific Institute, Italy

Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Spain

IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"- IRST, Italy

Haematology Division of Cancer and Genetics, Cardiff University, UK

VU University Medical Center Amsterdam, The Netherlands

Department of Medicine II, Goethe University Hospital, Germany

University Hospital of of Cologne, Köln (UOC), Germany